1
|
Awasthi N, Guo S and Wagner BJ: Posterior
capsular opacification: A problem reduced but not yet eradicated.
Arch Ophthalmol. 127:555–562. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Apple DJ, Solomon KD, Tetz MR, Assia EI,
Holland EY, Legler UF, Tsai JC, Castaneda VE, Hoggatt JP and
Kostick AM: Posterior capsule opacification. Surv Ophthalmol.
37:73–116. 1992. View Article : Google Scholar : PubMed/NCBI
|
3
|
McDonnell PJ, Krause W and Glaser BM: In
vitro inhibition of lens epithelial cell proliferation and
migration. Ophthalmic Surg. 19:25–30. 1988.PubMed/NCBI
|
4
|
de Iongh RU, Wederell E, Lovicu FJ and
McAvoy JW: Transforming growth factor-beta-induced
epithelial-mesenchymal transition in the lens: A model for cataract
formation. Cells Tissues Organs. 179:43–55. 2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
Saika S, Yamanaka O, Flanders KC, Okada Y,
Miyamoto T, Sumioka T, Shirai K, Kitano A, Miyazaki K, Tanaka S and
Ikeda K: Epithelial-mesenchymal transition as a therapeutic target
for prevention of ocular tissue fibrosis. Endocr Metab Immune
Disord Drug Targets. 8:69–76. 2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Barrallo-Gimeno A and Nieto MA: The snail
genes as inducers of cell movement and survival: Implications in
development and cancer. Development. 132:3151–3161. 2005.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Dawes LJ, Elliott RM, Reddan JR, Wormstone
YM and Wormstone IM: Oligonucleotide microarray analysis of human
lens epithelial cells: TGFbeta regulated gene expression. Mol Vis.
13:1181–1197. 2007.PubMed/NCBI
|
9
|
Verrecchia F and Mauviel A: Transforming
growth factor-beta signaling through the smad pathway: Role in
extracellular matrix gene expression and regulation. J Invest
Dermatol. 118:211–215. 2002. View Article : Google Scholar : PubMed/NCBI
|
10
|
Meng Q, Guo H, Xiao L, Cui Y, Guo R, Xiao
D and Huang Y: mTOR regulates TGF-β2 -induced
epithelial-mesenchymal transition in cultured human lens epithelial
cells. Graefes Arch Clin Exp Ophthalmol. 251:2363–2370. 2013.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Laplante M and Sabatini DM: mTOR signaling
at a glance. J Cell Sci. 122:3589–3594. 2009. View Article : Google Scholar : PubMed/NCBI
|
12
|
Hay N and Sonenberg N: Upstream and
downstream of mTOR. Genes Dev. 18:1926–1945. 2004. View Article : Google Scholar : PubMed/NCBI
|
13
|
Cantley LC: The phosphoinositide 3-kinase
pathway. Science. 296:1655–1657. 2002. View Article : Google Scholar : PubMed/NCBI
|
14
|
Downward J: Mechanisms and consequences of
activation of protein kinase B/Akt. Curr Opin Cell Biol.
10:262–267. 1998. View Article : Google Scholar : PubMed/NCBI
|
15
|
Su CH, Wang CY, Lan KH, Li CP, Chao Y, Lin
HC, Lee SD and Lee WP: Akt phosphorylation at Thr308 and Ser473 is
required for CHIP-mediated ubiquitination of the kinase. Cell
Signal. 23:1824–1830. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Xiong W, Cheng BH, Jia SB and Tang LS:
Involvement of the PI3K/Akt signaling pathway in platelet-derived
growth factor-induced migration of human lens epithelial cells.
Curr Eye Res. 35:389–401. 2010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Chandler HL, Webb TR, Barden CA,
Thangavelu M, Kulp SK, Chen CS and Colitz CM: The effect of
phosphorylated Akt inhibition on posterior capsule opacification in
an ex vivo canine model. Mol Vis. 16:2202–2214. 2010.PubMed/NCBI
|
18
|
Zhao L and Vogt PK: Class I PI3K in
oncogenic cellular transformation. Oncogene. 27:5486–5496. 2008.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Vlahos CJ, Matter WF, Hui KY and Brown RF:
A specific inhibitor of phosphatidylinositol 3-kinase,
2-(4-morpholinyl)-8-phenyl- 4H-1-benzopyran-4-one (LY294002). J
Biol Chem. 269:5241–5248. 1994.PubMed/NCBI
|
20
|
Yang XP, Liu TY, Qin XY and Yu LC:
Potential protection of
2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside against
staurosporine-induced toxicity on cultured rat hippocampus neurons.
Neurosci Lett. 576:79–83. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Cho HJ, Baek KE, Saika S, Jeong MJ and Yoo
J: Snail is required for transforming growth factor-beta-induced
epithelial-mesenchymal transition by activating PI3 kinase/Akt
signal pathway. Biochem Biophys Res Commun. 353:337–343. 2007.
View Article : Google Scholar
|
22
|
Yao K, Ye PP, Tan J, Tang XJ and Shen Tu
XC: Involvement of PI3K/Akt pathway in TGF-beta2-mediated
epithelial mesenchylmal transition in human lens epithelial cells.
Ophthalmic Res. 40:69–76. 2008. View Article : Google Scholar
|
23
|
Findl O, Buehl W, Bauer P and Sycha T:
Interventions for preventing posterior capsule opacification.
Cochrane Database Syst Rev. (2): CD0037382010.PubMed/NCBI
|
24
|
Biswas NR, Mongre PK, Das GK, Sen S, Angra
SK and Vajpayee RB: Animal study on the effects of catalin on after
cataract and posterior capsule opacification. Ophthalmic Res.
31:140–142. 1999. View Article : Google Scholar
|
25
|
Chandler HL, Barden CA, Lu P, Kusewitt DF
and Colitz CM: Prevention of posterior capsular opacification
through cyclooxy-genase-2 inhibition. Mol Vis. 13:677–691.
2007.PubMed/NCBI
|
26
|
Rabsilber TM and Auffarth GU:
Pharmacological means to prevent secondary cataract. Klin Monbl
Augenheilkd. 223:559–567. 2006.In German. View Article : Google Scholar : PubMed/NCBI
|